The iPS Cell-Derived Myocardial Sheets project involves the development of a cutting-edge cell therapy for severe heart failure using myocardial cells derived from human iPS cells. These cells are formed into sheets and transplanted onto the heart, with the aim of improving heart function and aiding recovery from heart failure. This therapy offers hope to patients for whom heart transplantation or artificial heart implantation are the only current options.

Basic information

Country

JAPAN

Group Name

Cuorips

Source

Source